SOD2 and infection: We demonstrated that both infection of C2C12 with specific PKCe shRNA and transfection of C2C12 with PKCe siRNA were capable of significantly reducing SOD2 protein content (Figure 4B–F), coupled by a significant decrease in levels of the intermediate marker of myogenic differentiation, Myogenin, as compared to control treatments (Figure 4B–F).